8 research outputs found

    Physical Chemical Parameters of Wastewater: A Case Study of Njoro Sewage Works, Nakuru, Kenya

    Get PDF
    Njoro sewage works is the main sewage work for Nakuru urban town that receives about 90% of industrial wastewater and 10 % domestic wastewater. In-sufficient pre-treatment of industrial wastewater, may affect the normal functioning of sewage works and the aquatic life (flora and fauna) of the receiving water body. The underground water aquifer may also be contaminated by both chemical elements and microbial through percolation. This study aimed at assessing the efficiency of the sewage works by analysing the physical and chemical parameters of wastewater from the inlet and outlet of Njoro sewage works. The study involved test analysis of the physical and chemical parameters in the laboratory and in-situ test. This study employed composite sampling method in the collection of samples. Data collection was done using experimental method while data analysis was done using descriptive statistics. This study found that BOD concentration was 400 mg/l for the influent and 150mg/l for effluent. COD concentration was 1399 mg/l for the influent and 222 mg/l for the effluent. DO concentrations were lower (0.05 mg/l) for influent and effluent. Traces of heavy metals were also found both for the influent and effluent. Njoro sewage works could not effectively reduce organic load in wastewater. Keywords: Discharge, Effluent, Influent, Sewage works, Wastewate

    A scoping review of market links between value chain actors and small-scale producers in developing regions

    Get PDF
    Sustainable Development Goal 2 aims to end hunger, achieve food and nutrition security and promote sustainable agriculture by 2030. This requires that small-scale producers be included in, and benefit from, the rapid growth and transformation under way in food systems. Small-scale producers interact with various actors when they link with markets, including product traders, logistics firms, processors and retailers. The literature has explored primarily how large firms interact with farmers through formal contracts and resource provision arrangements. Although important, contracts constitute a very small share of smallholder market interactions. There has been little exploration of whether non-contract interactions between small farmers and both small- and large-scale value chain actors have affected small farmers’ livelihoods. This scoping review covers 202 studies on that topic. We find that non-contract interactions, de facto mostly with small and medium enterprises, benefit small-scale producers via similar mechanisms that the literature has previously credited to large firms. Small and medium enterprises, not just large enterprises, address idiosyncratic market failures and asset shortfalls of small-scale producers by providing them, through informal arrangements, with complementary services such as input provision, credit, information and logistics. Providing these services directly supports Sustainable Development Goal 2 by improving farmer welfare through technology adoption and greater productivity

    Quality of Antimalarial Drugs Analysed in the National Quality Control Laboratory during the Period 2002–2005

    No full text
    During the period 2002–2005, the National Quality Control Laboratory analysed 229 samples of antimalarial drugs. In 2002, 42% of these products failed to comply with compendial specifications, with the sulfadoxine/ sulfamethoxypyrazine and pyrimethamine combination products forming 39% of the total failures. The respective percentages were 46% and 84% for 2003 and 36% and 72% for 2004. By May 2005, the only failures reported were of sulfadoxine/sulfamethoxypyrazine and pyrimethamine combination products. Until recently, sulfadoxine/sulfamethoxypyrazine and pyrimethamine combination products were the first-line malaria treatment regimen in Kenya. These analytical results raise concerns that the reported therapeutic failures associated with the use of these products could possibly be due to the administration of sub-standard sulfadoxine/sulfamethoxypyrazine and pyrimethamine combination products to patients. The same could be true of artemisinin based combinations which are the current first-line treatment regimen if the observed trend continues Keywords: Antimalarials, dissolution, assay, quality control testsEast and Central African Journal of Pharmaceutical Sciences Vol. 10 (3) 2007: pp. 59-6

    Evaluating Controlled Human Malaria Infection in Kenyan Adults with Varying Degrees of Prior Exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

    No full text
    Background: Controlled human malaria infection (CHMI) studies are a vital tool to accelerate vaccine and drug development. As CHMI trials are performed in a controlled environment, they allow unprecedented, detailed evaluation of parasite growth dynamics (PGD) and immunological responses. However, CHMI studies have not been routinely performed in malaria-endemic countries or used to investigate mechanisms of naturally-acquired immunity (NAI) to Plasmodium falciparum. Methods: We conducted an open-label, randomized CHMI pilot-study using aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) to evaluate safety, infectivity and PGD in Kenyan adults with low to moderate prior exposure to P. falciparum (Pan African Clinical Trial Registry: PACTR20121100033272). Results: All participants developed blood-stage infection confirmed by qPCR. However one volunteer (110) remained asymptomatic and blood-film negative until day 21 post-injection of PfSPZ Challenge. This volunteer had a reduced parasite multiplication rate (PMR) (1.3) in comparison to the other 27 volunteers (median 11.1). A significant correlation was seen between PMR and screening anti-schizont ELISA OD (p=0.044, R=-0.384) but not when volunteer 110 was excluded from the analysis (p=0.112, R=-0.313). Conclusions: PfSPZ Challenge is safe and infectious in malaria-endemic populations and could be used to assess the efficacy of malaria vaccines and drugs in African populations. Whilst our findings are limited by sample size, our pilot study has demonstrated for the first time that NAI may impact on PMR post-CHMI in a detectable fashion, an important finding that should be evaluated in further CHMI studies
    corecore